Steroids Fail to Deliver Clear Benefits in Infant Heart Surgery
Despite its size and novel design, the STRESS trial could not deliver an answer to the clinical conundrum of whether perioperative steroids are warranted.
Stay updated with breaking news from Patrick Ogara. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Despite its size and novel design, the STRESS trial could not deliver an answer to the clinical conundrum of whether perioperative steroids are warranted.
The weakened recommendation for CABG in patients with multivessel disease in a new guideline has some cardiac surgeons raising questions.
email article Transitioning high-sensitivity troponin testing protocols in the emergency department for suspected acute coronary syndrome can have some unintended consequences, studies showed. In a prospective multicenter trial from Australia, patients randomized to a 0/1-hour high-sensitivity cardiac troponin-T (hs-cTnT) protocol unmasked to the care team had similar all-cause mortality and MI at 12 months as those whose early levels were masked and were treated based on the standard protocol of 0/3-hour testing (5.0% vs 3.8%, HR 1.32, 95% CI 0.95-1.83). However, for those with an inte...
The Ross procedure is a double-valve operation using the patient’s pulmonary valve as an autograft to replace the damaged aortic valve, with pulmonary donor tissue used to reconstruct the continuity of right ventricular outflow and the pulmonary artery. It is most often performed in children, with good long-term results, and several recent studies — including a 2018 systematic review and meta-analysis — found clear benefits for the surgical procedure in selected young and middle-aged patients. “This study shows that the Ross procedure is an operation with potentially significant value...
email article In experienced hands, the Ross procedure was associated with favorable short- and long-term outcomes in young patients requiring aortic valve replacement (AVR), according to a retrospective cohort study. Survival was 95.1% at 10 years -- 88.5% at 15 years -- among more than 1,400 adults undergoing the double-valve procedure at highly specialized centers, Mostafa Mokhles, MD, PhD, of Utrecht University Medical Center in The Netherlands, and colleagues reported. "The Ross procedure continues to be the only living-valve alternative in young and middle-aged patients with a...